A Randomized Trial of a Resilience-Building Intervention in Adult Outpatients With Congenital Heart Disease: Feasibility and Efficacy
Authors' conclusion
This study demonstrates intervention feasibility with modifications. Although we did not demonstrate efficacy, participants were engaged and provided valuable feedback, suggesting value in ACHD.
Study context
- Population
- Outpatients with moderate or complex adult congenital heart disease
- Participants
- 78 outpatients
- Comparison
- PRISM vs usual care
- PRISMn = 40
- Usual caren = 38reference
- Primary endpoint
- Change in self-reported resilience
- Follow-up
- 3 months
Methodological detailsEnrolled March 2023 to April 2024
- Enrolled March 2023 to April 2024
Primary result
As reported in the abstract
Self-reported resilience score
- Difference not statistically significant
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
A Randomized Trial of a Resilience-Building Intervention in Adult Outpatients With Congenital Heart Disease: Feasibility and Efficacy. JACC Adv. Published 12 September 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →